Guardion Health Sciences Inc (GHSI) Return on Investment ROI from the second quarter of 2024 to second quarter of 2023 and for the year 2024, average high and low, overall ranking from Jun 30 2024 to Jun 30 2023 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Guardion Health Sciences Inc   (NASDAQ: GHSI)


Guardion Health Sciences Inc's ROI from its second quarter of 2024 to the second quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Guardion Health Sciences Inc's ROI in the second quarter of 2024?
Guardion Health Sciences Inc achieved a return on average invested assets (ROI) of 55.97 % in its second quarter of 2024 a new company high.

ROI has improved compared to -48.03% in the first quarter of 2024, due to net income growth.

Within the Healthcare sector 11 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2024 quarter, so far to 65, from total ROI ranking in the first quarter of 2024 at 2782.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter
Y / Y Investment Change TTM -27.28 % -41.73 % -42.29 % -37.04 % -36.91 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 14 9 11 11 11
Return On Investment (TTM) 55.97 % -48.03 % 1.38 % -69.44 % -66.19 %
GHSI's Overall Ranking # 65 # 2782 # 1716 # 4084 # 3950
Seq. Investment Change TTM 6.81 % -6.78 % -13.39 % -15.66 % -14.42 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions 6 -5 0 -9 -10

GHSI Company Profile >> Back to GHSI Roi Comparisons >> See Annual GHSI Return On Investment



Return On Investment GHSI's Ranking
Within: No.
Industry # 7
Sector # 12
Overall # 65

Return On Investment Statistics
High Average Low
55.97 %
-101.75 %
-236.39 %
(Jun 30 2024)   (Dec 31 2017)







Financial Statements
Guardion Health Sciences Inc's II. Quarter Investments $ 14 Millions GHSI's Balance sheet
Guardion Health Sciences Inc's II. Quarter Income $ 10 Millions Quarterly GHSI's Income Statement
GHSI's Income by Division See GHSI's Income by Division


GHSI Annual Return On Investment (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019
Total Investments in Millions 11 18 22 9 12
Y / Y Investment Growth -40.03 % -20.75 % 153.8 % -29.51 % 291.32 %
Net Income in Millions 0 -15 -25 -9 -11
Y / Y Net Income Growth - - - - -
Annual Return On Investment 1.49 % -84.43 % -110.96 % -97.55 % -87.26 %


Annual Roi Comment
In the fiscal year 2023 ROI improved to 1.49 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
GHSI's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for GHSI's Competitors
Subscribers only: Roi for Guardion Health Sciences Inc's Suppliers
Subscribers only: Return On Investment for GHSI's Customers

Other Ratios
GHSI's Roa GHSI's Inventory Turnover Ratio GHSI's Growth Rates GHSI's Dividend Statistics
GHSI's Profitability Ratios GHSI's Asset Turnover Ratio GHSI's Dividend Growth
GHSI's Roe GHSI's Valuation Ratios GHSI's Financial Strength Ratios GHSI's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2024, within Healthcare Sector ROI
Alaunos Therapeutics Inc   152.92 %
Camp4 Therapeutics Corporation  84.34 %
Roivant Sciences Ltd   77.20 %
Earth Science Tech Inc   73.25 %
Mimedx Group Inc   57.35 %
Guardion Health Sciences Inc   55.97 %
Biomx Inc  52.39 %
Entrada Therapeutics Inc   50.42 %
Siga Technologies Inc  50.32 %
Dariohealth Corp   50.05 %
Entera Bio Ltd   48.24 %
Scienture Holdings Inc   43.00 %
Protagonist Therapeutics inc   37.74 %
Mettler toledo International Inc   36.92 %
Medpace Holdings Inc   36.84 %
Valion Bio Inc   36.78 %
Nrc Health  36.51 %
Idexx Laboratories Inc  36.50 %
Pharmacyte Biotech Inc   36.30 %
Elite Pharmaceuticals Inc   33.34 %
Exelixis Inc   32.02 %
Johnson and Johnson  30.31 %
Sbc Medical Group Holdings Incorporated  28.61 %
Lantheus Holdings Inc   28.19 %
Cyclerion Therapeutics Inc   28.07 %
Lite Strategy Inc   27.58 %
Carlisle Companies Incorporated  25.54 %
Cytomx Therapeutics Inc   25.09 %
Iradimed Corporation  23.73 %
Corcept Therapeutics Inc  23.22 %

Date modified: 2026-09-12T06:22:35+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.